Sjögren's disease: open trials in Belgium

• NCT07737743

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven

  Registry updated 2026-10-28

• NCT07404865

  Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

  Trial Treatment · Phase 3 · Vor Biopharma

  Hopital Erasme, Anderlecht · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven

  Registry updated 2026-10-19

• NCT07873931

  A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases

  Trial Treatment · Phase 1 · Bristol-Myers Squibb

  Leuven

  Registry updated 2026-10-14

• NCT07760818

  A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)

  Trial Treatment · Phase 2 · argenx

  CHU Brugmann, Brussels · Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven

  Registry updated 2026-08-12

• NCT06747949

  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  Trial Treatment · Phase 3 · Amgen

  Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven

  Registry updated 2026-04-28

All Sjögren's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error